IHC-plus(tm) CHRNB2 Antibody (aa351-362)

LifeSpan BioSciences

IHC-plus(tm) CHRNB2 Antibody (aa351-362)

23

Peptide ELISA: antibody detection limit dilution 1:64000. Western blot: Approx. 48 kDa band observed in Human Brain (Cerebellum, Cerebral Cortex) lysates (calculated MW of 57.0 kDa according to NP_000739.1). The observed molecular weight corresponds to earlier findings with different antibodies from other commercial sources. Recommended concentration: 1-3 ug/ml.. IHC, IHC-P (3.75 µg/ml), Peptide-ELISA (1:64000), WB (1 - 3 µg/ml) Peptide ELISA: antibody detection limit dilution 1:64000. Western blot: Approx. 48 kDa band observed in Human Brain (Cerebellum, Cerebral Cortex) lysates (calculated MW of 57.0 kDa according to NP_000739.1). The observed molecular weight corresponds to earlier findings with different antibodies from other commercial sources. Recommended concentration: 1-3 ug/ml.

Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.5 mg/ml

Unconjugated

CHRNB2

cholinergic receptor nicotinic beta 2 subunit

EFNL3, nAChRB2, neuronal acetylcholine receptor subunit beta-2, acetylcholine receptor, nicotinic, beta 2 (neuronal), beta2 human neuronal nicotinic acetylcholine receptor, cholinergic receptor, nicotinic beta 2, cholinergic receptor, nicotinic, beta 2 (neuronal), cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), neuronal nicotinic acetylcholine receptor beta 2

Goat

Human, Mammals, Monkey

-20°C

41116161